102P CD4+ CAR-T cells induceimmunogenic cell death through noncanonical extracellular vesicle
Recently, CD4+ chimeric antigen receptor (CAR) T cells have emerged to play a pivotal role in CAR-T therapy. Besides the well acknowledged helper functions, it has been recognized that CD4+ CAR-T cells also possess direct target killing capacity. However, the unique killing mechanism specific for CD4+ CAR-T cells and their contribution to the efficacy of CAR-T therapy has not been thoroughly understood.
Authors
- H. Xian
- H. Liu
- Y. Wang
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2025.101187
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00